Tempus AI aims to raise up to $410.7 mln in US IPO
June 5 (Reuters) - Tempus AI is targeting to raise up to $410.7 million in its initial public offering in the United States, the genetics testing company said on Wednesday. (Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Krishna Chandra Eluri) ((ArasuKannagi.Basil@thomsonreuters.com;))
Recent news on Tempus AI
See all newsU.S. STOCKS ON THE MOVE-Tempus AI, Choice Hotels, Palantir
Tempus AI rises after surprise quarterly profit
Tempus AI Q3 revenue slightly beats estimates; raises guidance
Brief: Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling
Brief: Tempus Expands Strategic Collaboration With Bristol Myers Squibb